Koh Young Technology announced on the 10th that it showcased the brain surgery medical robot 'KYMERO' at the Korean Epilepsy Society's Surgical Committee workshop.
Introduced at Severance Hospital in 2020, KYMERO has been adopted by major hospitals in the country for surgeries involving complex brain diseases such as epilepsy and Parkinson's disease, gaining recognition for its accuracy and safety. By 2024, the cumulative number of surgical cases is expected to exceed 500.
The Korean Epilepsy Society is the most authoritative organization in the field of epilepsy research and treatment in the country, and the Surgical Committee workshop is designed for neurosurgeons and neurologists to share the latest surgical techniques and advanced medical technologies.
During the workshop's hands-on session, medical professionals used KYMERO directly, experiencing key functionalities such as surgical positioning and path guidance, and many were captivated by the technology's excellence and practicality.
KYMERO can be utilized for various high-precision brain surgeries, including sEEG (stereoelectroencephalography) for accurate seizure localization in refractory epilepsy. Additionally, it supports surgical plans for treatments like DBS (deep brain stimulation) for Parkinson's disease, and biopsies for confirming brain tumor sites, guiding the robot along planned paths.
One medical professional who participated in the workshop remarked, 'KYMERO is a medical robot that shortens surgery time and enhances accuracy,' adding, 'It was a valuable time to learn various surgical approaches through the workshop.'
A representative from Koh Young Technology noted, 'According to the World Health Organization (WHO), the sudden death rate for epilepsy patients is 30 times higher than that of the general population, but the number of hospitals capable of performing epilepsy surgeries in the country is very low, and the number of surgeries is also limited, making it difficult for patients to receive timely and appropriate treatment.' They expressed hope that KYMERO would provide a better treatment environment for patients requiring surgeries for complex brain diseases, including epilepsy.
Meanwhile, the global version of the brain surgery medical robot, Geniant Cranial, received certification (510k) from the U.S. Food and Drug Administration (FDA) last January and is expected to showcase Geniant Cranial at the AANS (American Association of Neurological Surgeons) conference in Boston this April.